BDBM50162979 CHEMBL175506::N-Benzothiazol-6-yl-6-methoxy-N''-(1-methyl-1-phenyl-ethyl)-[1,3,5]triazine-2,4-diamine

SMILES COc1nc(Nc2ccc3ncsc3c2)nc(NC(C)(C)c2ccccc2)n1

InChI Key InChIKey=AKDWJKHIBCIRSA-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50162979   

TargetVascular endothelial growth factor receptor 2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162979(N-Benzothiazol-6-yl-6-methoxy-N''-(1-methyl-1-phen...)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of KDR-induced MAP kinase autophosphorylation assay in HUVEC cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVascular endothelial growth factor receptor 2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162979(N-Benzothiazol-6-yl-6-methoxy-N''-(1-methyl-1-phen...)
Affinity DataIC50: 6.10E+3nMAssay Description:In vitro inhibition of Vascular endothelial growth factor receptor 2 at 10 uM ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed